QUOTED. 6 April 2020. Amy Abernethy.
The US Food and Drug Administration's second-in-command, Amy Abernethy, threw her support to acting commissioner Janet Woodcock in her exit interview with Medtech Insight.
“I feel very strongly about Janet Woodcock being the right person. I felt comfortable leaving my role because of the fact that Janet Woodcock is there.” – Amy Abernethy, principal deputy commissioner, US FDA
Click here for a free trial of Medtech Insight